158 related articles for article (PubMed ID: 23253072)
1. Graves' disease and toxic nodular goiter are both associated with increased mortality but differ with respect to the cause of death: a Danish population-based register study.
Brandt F; Thvilum M; Almind D; Christensen K; Green A; Hegedüs L; Brix TH
Thyroid; 2013 Apr; 23(4):408-13. PubMed ID: 23253072
[TBL] [Abstract][Full Text] [Related]
2. Hyperthyroid patients without Graves' orbitopathy are not at increased risk of developing glaucoma: a nationwide Danish register-based case-control study.
Brandt F; Thvilum M; Hegedüs L; Brix TH
Endocrine; 2018 Jan; 59(1):137-142. PubMed ID: 29198022
[TBL] [Abstract][Full Text] [Related]
3. Increased Cardiovascular Mortality and Morbidity in Patients Treated for Toxic Nodular Goiter Compared to Graves' Disease and Nontoxic Goiter.
Giesecke P; Rosenqvist M; Frykman V; Friberg L; Wallin G; Höijer J; Lönn S; Törring O
Thyroid; 2017 Jul; 27(7):878-885. PubMed ID: 28471268
[TBL] [Abstract][Full Text] [Related]
4. Graves' Disease and Toxic Nodular Goiter, Aggravated by Duration of Hyperthyroidism, Are Associated with Alzheimer's and Vascular Dementia: A Registry-Based Long-Term Follow-Up of Two Large Cohorts.
Folkestad L; Brandt F; Lillevang-Johansen M; Brix TH; Hegedüs L
Thyroid; 2020 May; 30(5):672-680. PubMed ID: 31984866
[No Abstract] [Full Text] [Related]
5. Death by Suicide in Graves' Disease and Graves' Orbitopathy: A Nationwide Danish Register Study.
Ferløv-Schwensen C; Brix TH; Hegedüs L
Thyroid; 2017 Dec; 27(12):1475-1480. PubMed ID: 29084476
[TBL] [Abstract][Full Text] [Related]
6. Mortality in Graves' orbitopathy is increased and influenced by gender, age and pre-existing morbidity: a nationwide Danish register study.
Schwensen CF; Brandt F; Hegedüs L; Brix TH
Eur J Endocrinol; 2017 Jun; 176(6):669-676. PubMed ID: 28258132
[TBL] [Abstract][Full Text] [Related]
7. Hyperthyroidism is associated with work disability and loss of labour market income. A Danish register-based study in singletons and disease-discordant twin pairs.
Brandt F; Thvilum M; Hegedüs L; Brix TH
Eur J Endocrinol; 2015 Nov; 173(5):595-602. PubMed ID: 26405237
[TBL] [Abstract][Full Text] [Related]
8. Decreased birth weight, length, and head circumference in children born by women years after treatment for hyperthyroidism.
Ohrling H; Törring O; Yin L; Iliadou AN; Tullgren O; Abraham-Nordling M; Wallin G; Hall P; Lönn S
J Clin Endocrinol Metab; 2014 Sep; 99(9):3217-23. PubMed ID: 24878049
[TBL] [Abstract][Full Text] [Related]
9. Relationship between the number and impact of stressful life events and the onset of Graves' disease and toxic nodular goitre.
Matos-Santos A; Nobre EL; Costa JG; Nogueira PJ; Macedo A; Galvão-Teles A; de Castro JJ
Clin Endocrinol (Oxf); 2001 Jul; 55(1):15-9. PubMed ID: 11453947
[TBL] [Abstract][Full Text] [Related]
10. No link between season of birth and subsequent development of Graves' disease or toxic nodular goitre: a nationwide Danish register-based study.
Sivalingam S; Thvilum M; Brix TH; Hegedüs L; Brandt F
Endocr Connect; 2018 Aug; 7(10):1090-5. PubMed ID: 30139815
[TBL] [Abstract][Full Text] [Related]
11. Iodine-131 given for therapeutic purposes modulates differently interferon-gamma-inducible alpha-chemokine CXCL10 serum levels in patients with active Graves' disease or toxic nodular goiter.
Antonelli A; Rotondi M; Fallahi P; Grosso M; Boni G; Ferrari SM; Romagnani P; Serio M; Mariani G; Ferrannini E
J Clin Endocrinol Metab; 2007 Apr; 92(4):1485-90. PubMed ID: 17244787
[TBL] [Abstract][Full Text] [Related]
12. Improved quality of life in hyperthyroidism patients after surgery.
Bukvic B; Zivaljevic V; Sipetic S; Diklic A; Tausanovic K; Stojanovic D; Stevanovic D; Paunovic I
J Surg Res; 2015 Feb; 193(2):724-30. PubMed ID: 25167783
[TBL] [Abstract][Full Text] [Related]
13. Excess mortality in hyperthyroidism: the influence of preexisting comorbidity and genetic confounding: a danish nationwide register-based cohort study of twins and singletons.
Brandt F; Almind D; Christensen K; Green A; Brix TH; Hegedüs L
J Clin Endocrinol Metab; 2012 Nov; 97(11):4123-9. PubMed ID: 22930783
[TBL] [Abstract][Full Text] [Related]
14. Smoking as a risk factor for Graves' disease, toxic nodular goiter, and autoimmune hypothyroidism.
Vestergaard P; Rejnmark L; Weeke J; Hoeck HC; Nielsen HK; Rungby J; Laurberg P; Mosekilde L
Thyroid; 2002 Jan; 12(1):69-75. PubMed ID: 11838733
[TBL] [Abstract][Full Text] [Related]
15. HLA antigens in Greek patients with thyrotoxicosis (Graves' disease and toxic nodular goiter).
Papasteriades C; Alevizaki-Harhalaki MN; Economidou J; Ikkos DG
J Endocrinol Invest; 1984 Aug; 7(4):283-6. PubMed ID: 6594386
[TBL] [Abstract][Full Text] [Related]
16. Th1 and Th2 serum cytokine profiles characterize patients with Hashimoto's thyroiditis (Th1) and Graves' disease (Th2).
Phenekos C; Vryonidou A; Gritzapis AD; Baxevanis CN; Goula M; Papamichail M
Neuroimmunomodulation; 2004; 11(4):209-13. PubMed ID: 15249726
[TBL] [Abstract][Full Text] [Related]
17. COMPARISON OF CARDIAC ARRHYTHMIA TYPES BETWEEN HYPERTHYROID PATIENTS WITH GRAVES' DISEASE AND TOXIC NODULAR GOITER.
Turan E; Can I; Turan Y; Uyar M; Cakır M
Acta Endocrinol (Buchar); 2018; 14(3):324-329. PubMed ID: 31149279
[TBL] [Abstract][Full Text] [Related]
18. Effect of stressful life events on the initiation of graves' disease.
Topcu CB; Celik O; Tasan E
Int J Psychiatry Clin Pract; 2012 Oct; 16(4):307-11. PubMed ID: 22136213
[TBL] [Abstract][Full Text] [Related]
19. Increase of interferon-gamma-inducible CXC chemokine CXCL10 serum levels in patients with active Graves' disease, and modulation by methimazole therapy.
Antonelli A; Rotondi M; Fallahi P; Romagnani P; Ferrari SM; Barani L; Ferrannini E; Serio M
Clin Endocrinol (Oxf); 2006 Feb; 64(2):189-95. PubMed ID: 16430719
[TBL] [Abstract][Full Text] [Related]
20. Iodine-131 treatment of hyperthyroidism: significance of effective half-life measurements.
Berg GE; Michanek AM; Holmberg EC; Fink M
J Nucl Med; 1996 Feb; 37(2):228-32. PubMed ID: 8667049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
